Moderna flu shot, vaccine confidence, baby food: Morning Rounds
The FDA recently made headlines by refusing to review Moderna’s application for a new flu vaccine, a decision that has raised concerns about the agency’s stance on vaccines. This surprising move comes at a time when confidence in the safety of certain vaccines, including flu, Covid-19, and MMR, is reportedly dropping according to new polling data.
In related news, a legal settlement in Washington state has set a precedent protecting harm reduction programs like syringe exchanges under the Americans with Disabilities Act. This development is significant as it ensures access to lifesaving services for individuals struggling with addiction.
Additionally, the FDA has announced plans to reassess the safety of a chemical preservative called butylated hydroxyanisole (BHA), commonly used in various food products. This move is part of a larger agenda to increase oversight of chemicals in the food supply.
On a different note, a recent study published in Nutrients revealed that 71% of baby food products can be classified as ultra-processed foods, containing excessive amounts of sugar, sodium, and calories. This finding underscores the importance of monitoring the nutritional content of baby foods to ensure the health and well-being of infants.
Furthermore, a poignant First Opinion essay sheds light on why clinical trials often exclude patients with rare diseases, leaving families without viable treatment options. The author advocates for changes in incentives to encourage greater inclusivity in clinical trials for rare diseases.
In other news, the FTC has launched an investigation targeting medical nonprofits involved in transgender children’s health, while a fascinating New Yorker article delves into the mysterious world of babies kept in a Los Angeles mansion. Novartis’ biomedical research head shares insights on AI, pipeline management, and potential blockbuster drugs, and NPR explores a complex brain network that may explain some of Parkinson’s more unusual symptoms.
Overall, these developments highlight the importance of ongoing research, regulatory oversight, and advocacy efforts in the fields of healthcare and medicine. Stay informed and engaged with the latest updates in health and medicine by subscribing to STAT’s free newsletter Morning Rounds.
